
    
      This study is a 4 Period study consists of 16 visits with overnight clinic stays that span
      over year to help determine the efficacy of TBS-1 gel administered twice daily (b.i.d) and
      three times daily (t.i.d)

      In addition, this study will investigate the safety and tolerability of TBS-1 after 90, 180
      and 360 days of treatment.
    
  